Organon & Co october 27, 2025 Please complete the form below to contact Kaplan Fox regarding the Organon & Co Investigation: Join a Case First Name * Last Name * Email Address * Phone Number * Ticker Symbol Or Company Name * Please Insert Your Estimation Of Losses In USD * Are you a current or former employee of the company mentioned having traded above? * Yes No Captcha Submit If you are human, leave this field blank. Principle Contacts Pamela MayerPMayer@kaplanfox.comLaurence D. KingLKing@kaplanfox.com Kaplan Fox is Investigating Organon & Co. (OGN) Following an Announcement of Findings of an Audit Committee Investigation and CEO Resignation Kaplan Fox & Kilsheimer LLP is investigating potential securities violations concerning Organon & Co. (“Organon” or the “Company”) (NYSE: OGN). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THE ORGANON INVESTIGATION If you purchased Organon securities and have suffered losses, you may CLICK HERE to contact us. You may also contact Kaplan Fox by emailing pmayer@kaplanfox.com or by calling (646) 315-9003. On October 27, 2025, Organon issued a press release disclosing that “[a]fter concerns regarding the Company’s wholesaler sales practices for its Nexplanon® product were brought to the Board’s attention, the Audit Committee of the Board oversaw an independent, internal investigation into its sales to wholesalers.” Further, the Company disclosed that “the investigation found that certain wholesalers in the United States were asked to buy more Nexplanon than they needed at the end of the fourth quarter of 2022, the third and fourth quarters of 2024 and the first, second and third quarters of 2025” and that this “enabled Organon to meet guidance and/or certain external revenue expectations.” Following this news, the price of Organon shares fell over $2 per share, or nearly 26%, during intraday trading on October 27, 2025. WHY CONTACT KAPLAN FOX Kaplan Fox is a leading national law firm focusing on complex litigation with offices in New York, Oakland, Los Angeles, Chicago and New Jersey. With over 50 years of experience in securities litigation, Kaplan Fox offers the professional experience and track record that clients demand. Through prosecuting cases on the federal and state levels, Kaplan Fox has successfully shaped the law through winning many important decisions on behalf of our clients. For more information about Kaplan Fox & Kilsheimer LLP, you may visit our website at www.kaplanfox.com. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. If you have any questions about this investigation, please contact: CONTACT:Pamela A. MayerKAPLAN FOX & KILSHEIMER LLP800 Third Avenue, 38th FloorNew York, New York 10022(646) 315-9003pmayer@kaplanfox.com Laurence D. KingKAPLAN FOX & KILSHEIMER LLP1999 Harrison Street, Suite 1560Oakland, California 94612(415) 772-4704lking@kaplanfox.com The submission of this form does not create an attorney-client relationship, nor an obligation on the part of Kaplan Fox to retain you as a client. Any information you submit will be maintained as confidential. If Kaplan Fox, in its sole discretion, believes that you might be an appropriate client, Kaplan Fox will contact you to discuss the matter and whether to establish an attorney client relationship. By signing this form you are authorizing us to contact you regarding this case and/or future cases. Connect with Kaplan Fox. Receive a complimentary case review now. Contact Us Organon & Co See the Case Marex Group plc See the Case CarMax, Inc. See the Case Fluor Corporation See the Case KBR, Inc. See the Case RCI Hospitality Holdings, Inc. See the Case Barnes & Noble Education, Inc. See the Case Dow, Inc. See the Case Semler Scientific, Inc. See the Case LifeMD, Inc. See the Case C3.ai, Inc. See the Case Snap, Inc. See the Case
